Disclosure Of Intangible Assets [Text Block]

Zealand Pharma - Filing #5889383

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of intangible assets [text block]
3
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
12,620,000 DKK
12,255,000 DKK
Research and development expense
919,866,000 DKK
684,902,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.